Addus HomeCare Q3 adjusted EPS beats estimates; to acquire AccentCare personal care division
Overview
U.S. home care provider's Q3 service revenue rose 7% yr/yr
Q3 adjusted EPS rose 17% and beat analyst expectations
Company to acquire AccentCare personal care division, expanding revenue base by nearly 19%
Outlook
Company expects to close and integrate AccentCare personal care acquisition in coming quarters
Addus plans to pursue further acquisitions to expand market density and operational scale
Company anticipates continued profitable growth through end of 2026
Result Drivers
PERSONAL CARE GROWTH - Co said personal care services drove Q3 growth, aided by organic volume expansion, acquisition contribution and favorable rate adjustments
HOSPICE SEGMENT - Hospice segment saw higher average daily census and organic revenue growth, excluding prior year price concession effects
HOME HEALTH RECOVERY - Home health segment showed improved admission and volume trends, returning to organic revenue growth
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Adjusted EPS | Beat | $1.83 | $1.80 (14 Analysts) |
Q3 Net Income | $28.60 mln | ||
Q3 Adjusted EBITDA | Beat | $51.20 mln | $50.29 mln (13 Analysts) |
Q3 Operating Cash Flow | $40.90 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Addus Homecare Corp is $137.00, about 8.9% above its November 2 closing price of $125.75
The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 16 three months ago
Reuters Recommended Reads
Nov 2 - Diversified Healthcare Trust Q3 net loss narrows amid occupancy growth
Nov 3 - AdaptHealth posts Q3 loss due to goodwill impairment charge
Nov 3 - Syra Health Q3 revenue jumps to record high on workforce contracts
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)